| Literature DB >> 18501014 |
Beate Hanson1, Chris van der Werken, Dirk Stengel.
Abstract
BACKGROUND: The routine removal of orthopaedic fixation devices after fracture healing remains an issue of debate. There are no evidence-based guidelines on this matter, and little is known on surgeons' practice and perceived effectiveness of implant removal in different clinical settings.Entities:
Mesh:
Year: 2008 PMID: 18501014 PMCID: PMC2430567 DOI: 10.1186/1471-2474-9-73
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Demographic profile of the respondents.
| Mean age, years (SD) | 38.8 (9.3) |
| Median age, years (range) | 36 (26 – 71) |
| Gender | |
| Male | 571 (87.2%) |
| Female | 84 (12.8%) |
| Professional background | |
| General surgeon | 96 (14.7%) |
| Orthopedic surgeon | 361 (55.2%) |
| Trainee | 121 (18.5%) |
| Spine surgeon | 7 (1.1%) |
| Other | 69 (10.6%) |
| Affiliation | |
| University hospital | 277 (42.3%) |
| Public, non-university hospital | 303 (46.3%) |
| Private hospital | 61 (9.3%) |
| Other | 14 (2.1%) |
| Current position | |
| Chief of staff | 128 (20.0%) |
| Consultant | 174 (27.1%) |
| Intern/resident | 215 (33.5%) |
| Other | 124 (19.3%) |
| Origin | |
| Africa | 29 (4.5%) |
| Asia | 58 (9.0%) |
| Australia | 8 (1.2%) |
| Europe | 470 (72.9%) |
| North America | 38 (5.9%) |
| South America | 42 (6.5%) |
Proportions of agreement and disagreement in statements about general attitudes towards implant removal.
| Orthopedic implants must be removed in younger patients (<40 years of age), even if they cause no problems | 645 | 39 (6.0%) [4.3–8.2%] | 200 (31.0%) [27.5–34.7%] | 33 (5.1%) [3.5–7.1%] | 297 (46.0%) [42.1–50.0%] | 76 (11.8%) [9.4–14.5%] |
| Leaving implants in-situ poses a risk for later fractures | 645 | 15 (2.3%) [1.3–3.8%] | 212 (32.9%) [29.3–36.6%] | 104 (16.1%) [13.4–19.2%] | 287 (44.5%) [40.6–48.4%] | 27 (4.2%) [2.8–6.0%] |
| Titanium implants are safer to be kept in-situ than devices made from stainless steel | 647 | 48 (7.4%) [5.5–9.7%] | 252 (38.9%) [35.2–42.8%] | 180 (27.8%) [24.4–31.4%] | 148 (22.9%) [19.7–26.3%] | 19 (2.9%) [1.8–4.5%] |
| In case of otherwise unexplained pain and functional deficits, implant removal is a good option to improve the physical status | 646 | 51 (7.9%) [5.9–10.2%] | 394 (61.0%) [57.1–64.8%] | 78 (12.1%) [9.7–14.8%] | 111 (17.2%) [14.4–20.3%] | 12 (1.9%) [1.0–3.2%] |
| Leaving implants in-situ increases the life-time risk for chronic infections, allergy, and cancer | 649 | 15 (2.3%) [1.3–3.8%] | 107 (16.5%) [13.7–19.6%] | 150 (23.1%) [19.9–26.6%] | 310 (47.8%) [43.9–51.7%] | 67 (10.3%) [8.1–12.9%] |
| Removing implants is a surgical procedure which drains valuable hospital resources | 644 | 114 (17.7%) [14.8–20.9%] | 436 (67.7%) [63.9–71.3%] | 21 (3.3%) [2.0–4.9%] | 71 (11.0%) [8.7–13.7%] | 2 (0.3%) [0.0–1.1%] |
| Removing implants damages healed soft tissue, and is riskier than retaining the device | 643 | 29 (4.5%) [3.0–6.4%] | 281 (43.7%) [39.8–47.6%] | 75 (11.7%) [9.3–14.4%] | 243 (37.8%) [34.0–41.7%] | 15 (2.3%) [1.3–3.8%] |
| Given the time and efforts required for implant removal, this procedure is not adequately reimbursed by insurance companies | 642 | 46 (7.2%) [5.3–9.4%] | 190 (29.6%) [26.1–33.3%] | 285 (44.4%) [40.5–48.3%] | 112 (17.4%) [14.6–20.6%] | 9 (1.4%) [0.6–2.6%] |
| Patients should take responsibility for the incurring costs of implant removal | 642 | 15 (2.3%) [1.3–3.8%] | 109 (17.0%) [14.2–20.1%] | 91 (14.2%) [11.6–17.1%] | 328 (51.1%) [47.1–55.0%] | 99 (15.4%) [12.7–18.5%] |
n = number of available answers. Percentages in brackets are 95% confidence intervals.
Figure 1Assigned removal priority to different types of implants. Mean ratings on 10-point scales with 95% confidence intervals.
Figure 2Main indications for implant removal. Mean ratings on 10-point scales with 95% confidence intervals.
Variables contributing to the likelihood of agreement in the different statements about general attitudes towards implant removal.
| Orthopedic implants must be removed in younger patients (<40 years of age), even if they cause no problems | 1.03 (1.01–1.04) | 1.12 (0.74–1.70) | 1.23 (0.92–1.64) | 7.40 (3.77–14.50) | 1.56 (1.12–2.18) | 0.72 (0.54–0.97) |
| Leaving implants in-situ poses a risk for later fractures | 0.99 (0.98–1.01) | 1.32 (0.86–2.02) | 1.13 (0.84–1.50) | 2.81 (1.44–5.47) | 0.98 (0.71–1.35) | 0.79 (0.59–1.06) |
| Titanium implants are safer to be kept in-situ than devices made from stainless steel | 1.02 (1.00–1.04) | 0.82 (0.54–1.22) | 0.72 (0.54–0.96) | 2.16 (1.18–3.97) | 1.05 (0.76–1.45) | 1.04 (0.78–1.38) |
| In case of otherwise unexplained pain and functional deficits, implant removal is a good option to improve the physical status | 1.00 (0.98–1.02) | 0.86 (0.53–1.38) | 0.73 (0.54–1.00) | 2.74 (1.47–5.11) | 1.81 (1.28–2.55) | 0.83 (0.61–1.13) |
| Leaving implants in-situ increases the life-time risk for chronic infections, allergy, and cancer | 1.01 (0.99–1.03) | 1.14 (0.74–1.76) | 1.26 (0.94–1.68) | 1.66 (0.90–3.08) | 0.99 (0.72–1.37) | 0.92 (0.69–1.22) |
| Removing implants is a surgical procedure which drains valuable hospital resources | 1.00 (0.98–1.02) | 1.51 (0.91–2.48) | 0.99 (0.72–1.38) | 1.39 (0.68–2.84) | 1.11 (0.77–1.60) | 1.08 (0.78–1.50) |
| Removing implants damages healed soft tissue, and is riskier than retaining the device | 0.99 (0.97–1.00) | 1.06 (0.69–1.64) | 0.91 (0.68–1.22) | 1.20 (0.65–2.23) | 1.20 (0.65–2.23) | 1.36 (1.01–1.82) |
| Given the time and efforts required for implant removal, this procedure is not adequately reimbursed by insurance companies | 1.02 (1.00–1.03) | 1.41 (0.93–2.14) | 1.43 (1.07–1.91) | 0.37 (0.19–0.70) | 0.37 (0.19–0.70) | 1.25 (0.93–1.67) |
| Patients should take responsibility for the incurring costs of implant removal | 1.03 (1.01–1.05) | 2.39 (1.52–3.76) | 1.61 (1.20–2.16) | 0.48 (0.26–0.91) | 0.24 (0.17–0.34) | 1.31 (0.98–1.75) |
Numbers are odds ratios derived from ordered logistic regression, with 95% confidence intervals in parentheses. Values >1 indicate a higher likelihood of agreement, and values <1 indicate a higher likelihood in disagreement. If the 95% confidence limits exclude 1, statistically significant results can be assumed at the two-tailed 5% threshold.
Uncontrolled studies of the effectiveness of implant removal in symptomatic patients. Success includes complete or marked reduction of pain
| Richards [30] | 1992 | various | 46 | 42 | 91% (79 – 98%) | 4 | 9% (2 – 21%) |
| Jacobsen [31] | 1994 | ankle plates | 66 | 49 | 74% (62 – 84%) | 17 | 26% (16 – 38%) |
| Court-Brown [32] | 1997 | intramedullary tibial nails | 62 | 60 | 97% (88 – 99%) | 2 | 3% (0 – 11%) |
| Dodenhoff [33] | 1997 | intramedullary femoral nails | 17 | 11 | 65% (38 – 86%) | 6 | 35% (14 – 62%) |
| Keating [34] | 1997 | intramedullary tibial nails | 49 | 39 | 80% (66 – 90%) | 10 | 20% (10 – 34%) |
| Brown [7] | 2001 | ankle plates | 22 | 11 | 50% (28 – 72%) | 11 | 50% (28 – 72%) |
| Gösling [6] | 2004 | intramedullary femoral nails | 58 | 45 | 78% (65 – 87%) | 13 | 22% (13 – 35%) |
| Gösling [24] | 2005 | intramedullary tibial nails | 26 | 19 | 73% (52 – 88%) | 7 | 27% (12 – 48%) |
| Weighted average | 346 | 78% (69 – 88%) | 22% (12 – 31%) | ||||
Failure includes no change and worsening of symptoms. Summary estimates were derived from random-effects meta-regression analysis